Protocol
GLP-1 and incretin-pathway research.
Research has examined this combination across the GLP-1 (Semaglutide), dual GIP/GLP-1 (Tirzepatide), and triple GIP/GLP-1/glucagon (Retatrutide) incretin-receptor agonist pharmacology.
For research use only. References for each compound on the Science page.
Catalog links
RECODEX supplies research-grade peptides intended for in-vitro laboratory research and bench-scale experimentation by qualified researchers. Our products are not intended for human or veterinary diagnostic, therapeutic, or recreational use.
